The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry

Antoinetta J. M. Beijers; Simone Oerlemans; Floortje Mols; Marijke Eurelings; Monique C. Minnema; Art Vreugdenhil; Lonneke V. van de Poll-Franse

doi:10.1007/s00277-017-2927-8

The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry

Antoinetta J. M. Beijers^*, Simone Oerlemans, Floortje Mols, Marijke Eurelings, Monique C. Minnema, Art Vreugdenhil, Lonneke V. van de Poll-Franse

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	653-663
Number of pages	11
Journal	Annals of Hematology
Volume	96
Issue number	4
DOIs	https://doi.org/10.1007/s00277-017-2927-8
Publication status	Published - Apr 2017

Keywords

Chemotherapy-induced peripheral neuropathy
Neuropathy
Treatment
Dose modification
Multiple myeloma
QUALITY-OF-LIFE
INDUCED PERIPHERAL NEUROPATHY
COMMON TERMINOLOGY CRITERIA
PROTEASOME INHIBITOR
ADVERSE EVENTS
BORTEZOMIB
QUESTIONNAIRE
REVERSIBILITY
DEXAMETHASONE
LENALIDOMIDE

Access to Document

10.1007/s00277-017-2927-8

Cite this

Beijers, Antoinetta J. M. ; Oerlemans, Simone ; Mols, Floortje ; Eurelings, Marijke ; Minnema, Monique C. ; Vreugdenhil, Art ; van de Poll-Franse, Lonneke V. / The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications : results from the population-based PROFILES registry. In: Annals of Hematology. 2017 ; Vol. 96, No. 4. pp. 653-663.

@article{caffb162af744e05b453f733517d74e2,

title = "The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry",

keywords = "Chemotherapy-induced peripheral neuropathy, Neuropathy, Treatment, Dose modification, Multiple myeloma, QUALITY-OF-LIFE, INDUCED PERIPHERAL NEUROPATHY, COMMON TERMINOLOGY CRITERIA, PROTEASOME INHIBITOR, ADVERSE EVENTS, BORTEZOMIB, QUESTIONNAIRE, REVERSIBILITY, DEXAMETHASONE, LENALIDOMIDE",

author = "Beijers, {Antoinetta J. M.} and Simone Oerlemans and Floortje Mols and Marijke Eurelings and Minnema, {Monique C.} and Art Vreugdenhil and {van de Poll-Franse}, {Lonneke V.}",

year = "2017",

month = apr,

doi = "10.1007/s00277-017-2927-8",

language = "English",

volume = "96",

pages = "653--663",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer",

number = "4",

}

The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications : results from the population-based PROFILES registry. / Beijers, Antoinetta J. M.; Oerlemans, Simone; Mols, Floortje; Eurelings, Marijke; Minnema, Monique C.; Vreugdenhil, Art; van de Poll-Franse, Lonneke V.

In: Annals of Hematology, Vol. 96, No. 4, 04.2017, p. 653-663.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications

T2 - results from the population-based PROFILES registry

AU - Beijers, Antoinetta J. M.

AU - Oerlemans, Simone

AU - Mols, Floortje

AU - Eurelings, Marijke

AU - Minnema, Monique C.

AU - Vreugdenhil, Art

AU - van de Poll-Franse, Lonneke V.

PY - 2017/4

Y1 - 2017/4

KW - Chemotherapy-induced peripheral neuropathy

KW - Neuropathy

KW - Treatment

KW - Dose modification

KW - Multiple myeloma

KW - QUALITY-OF-LIFE

KW - INDUCED PERIPHERAL NEUROPATHY

KW - COMMON TERMINOLOGY CRITERIA

KW - PROTEASOME INHIBITOR

KW - ADVERSE EVENTS

KW - BORTEZOMIB

KW - QUESTIONNAIRE

KW - REVERSIBILITY

KW - DEXAMETHASONE

KW - LENALIDOMIDE

U2 - 10.1007/s00277-017-2927-8

DO - 10.1007/s00277-017-2927-8

M3 - Article

C2 - 28116479

VL - 96

SP - 653

EP - 663

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 4

ER -